Grant Success! StickyCell joins with Dr Stefan Blum to study treatment effects for Multiple Sclerosis patients.
StickyCell, in partnership with Dr Stefan Blum, a leading neurologist at Princess Alexandra Hospital in Brisbane, is conducting an important study investigating therapy effects in individuals with multiple sclerosis (MS).
A recently awarded project grant from Multiple Sclerosis Research Australia has enabled a research and development collaboration between Dr Blum and StickyCell to improve the safety and affordability of one of the most effective drugs on the market for the treatment of MS – natalizumab (Tysabri©). The project hopes to develop a more personalised treatment plan for patients, see a reduction in drug administration, lessen the adverse side effects experienced by patients and ease the economic burden on the healthcare system.
Please refer to our previous article on StickyCell’s website for more information on the research activity of this project.